info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Neurosyphilis Market information, by type (asymptomatic neurosyphilis, meningeal neurosyphilis, and others), diagnosis (asymptomatic neurosyphilis, meningeal neurosyphilis, and others), by treatment (antibiotic penicillin, and others), by end user- Forecast till 2032


ID: MRFR/Pharma/2704-HCR | 80 Pages | Author: Rahul Gotadki| November 2024

Neurosyphilis Market Overview


Neurosyphilis Market Size was valued at USD 1.58 Billion in 2023. The Global Neurosyphilis industry is projected to grow from USD 1.71 Billion in 2024 to USD 3.21 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 9.10% during the forecast period (2024 - 2032).


Neurosyphilis is the infection of spinal cord and brain. It is most common in an individual who have untreated syphilis for long period of time. This is mainly caused due to bacteria called Treponema pallidum. This is the bacteria which causes syphilis. After getting infected with syphilis for the first time, there are chances of neurosyphilis after 10-20 years later. 


The major symptoms of neurosyphilis are blindness, abnormal walk, confusion, depression, dementia, headache, irritability, incontinence, poor concentration, numbness in the toes, feet, or legs, seizures, tremors, stiff neck, visual disturbances, and weaknspinal cordgically advanced diagnostic medical devices are another important driver for the market. Some other factors like increasing awareness, rising demand from emerging markets, government support to improve public healthcare, and changing healthcare practices are also major factors for the market growth.


Key Players for Global Neurosyphilis Market   


Some of the key players in this market are: 



  • Abbott (US)

  • Bayer AG (Germany)

  • Eli Lilly and Company (US)

  • GlaxoSmithKline plc. (UK)

  • Novartis AG (Switzerland)

  • Pfizer Inc. (US)

  • Sanofi (France)


Neurosyphilis Market Segmentation  


Global neurosyphilis market has been segmented on the basis of type which comprise asymptomatic neurosyphilis, meningeal neurosyphilis, meningovascular neurosyphilis, general paresis, tabes dorsalis, and others.


On the basis of diagnosis, the neurosyphilis market is segmented into physical exam, blood test, spinal tap, imaging tests, and others. Blood test is further subsegmented into Venereal disease research laboratory (VDRL) test, Fluorescent treponemal antibody absorption (FTA-ABS), Rapid plasma reagin (RPR), Treponema pallidum particle agglutination assay (TPPA), and others. Imaging tests is further sub-segmented into Computed Tomography (CT), X-rays, Magnetic resonance imaging (MRI), and others.


On the basis of treatments, the market has been segmented into antibiotic penicillin, antibiotics probenecid, ceftriaxone and others. Antibiotic penicillin is further sub-segmented into Injection and oral.


On the basis of end user, it is segmented into hospital and clinics, medical research centers, academic institutes, and others.


Regional Analysis of Neurosyphilis Market                  


Considering the global scenario of the market, the Americas are holding the largest market for neurosyphilis. The Americas mainly include North America and Latin America, out of which North America is holding majority of market share of this region. US is the top revenue generating market in North America and is one of the important markets for global neurosyphilis. 


Various factors are leading the market growth such as availability of funding for research and clinical trials, and advanced diagnostic and treatment options. Latin America neurosyphilis market is also growing significantly and mainly includes Brazil, Argentina and Chile.  Europe is the second largest and one of the important markets for neurosyphilis. Increasing cases of neurosyphilis is a key driving factor for this market. Europe is mainly divided into Eastern Europe and Western Europe. 


More developed western European countries like Germany, UK and France are dominating this market while East European region is also growing significantly. Asia Pacific region is showing the fastest growth rate in global neurosyphilis market due to some major factors such as increasing awareness of the disorder and related care, increasing investment in research, and rapidly improving healthcare facilities. Japan is holding major market share while China neurosyphilis market is expected to have fastest growth in this region. 


Governments of different Asia nations are taking various initiatives to increase awareness of this disease that plays important role in the growth of this market. Middle East & Africa is expected to have a limited growth due to lack of knowledge of disease, traditional healthcare practices etc. Middle East region is dominating this market due to some major factors like developed healthcare facilities and government support to improve public health.


Intended Audience:



  • Neurosyphilis diagnostic and treatment supplies companies

  • Neurosyphilis diagnostic and treatment supplies providers

  • Medical research laboratories

  • Research and Development (R&D) Companies

  • Market Research and Consulting Service Providers

  • Potential Investors

Report Attribute/Metric Details
  Market Size   2032: USD 3.21 Billion
  CAGR   2024-2032:9.10%
  Base Year   2021
  Forecast Period   2024-2032
  Historical Data   2020
  Forecast Units   Value (USD Million)
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered By Type, Diagnosis, Treatment, End User
Geographies Covered North America, Europe, Asia-Pacific, and Rest of the World (RoW)
 Key Vendors Abbott (US), Bayer AG (Germany), Eli Lilly and Company (US), GlaxoSmithKline plc. (UK), Novartis AG (Switzerland), Pfizer Inc. (US), Sanofi (France)
Key Market Opportunities The Americas are holding the largest market for neurosyphilis Europe is the second largest and one of the important markets for neurosyphilis
Key Market Drivers Clinical trials, funding for research, and adoption of advanced diagnostic devices


Frequently Asked Questions (FAQ) :

neurosyphilis market is expected to exhibit a CAGR of 9.10% from 2024 to 2032.

neurosyphilis market is predicted to touch USD 3.21 Billion by 2032.

Clinical trials, funding for research, and adoption of advanced diagnostic devices are major drivers of the global neurosyphilis market.

North America can dominate the global neurosyphilis market.

The Middle East & Africa (MEA) can showcase the lowest growth rate in the global neurosyphilis market.

Bayer AG, Novartis AG, Abbott, GlaxoSmithKline plc., Sanofi, Pfizer Inc., and Eli Lilly and Company are notable players of the global neurosyphilis market.

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.